Sol-Gel Technologies (SLGL) EPS (Basic) (QoQ) (2018 - 2026)
Sol-Gel Technologies (SLGL) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.91% |
| Dec 31, 2025 | -884.62% |
| Sep 30, 2025 | -155.99% |
| Jun 30, 2025 | 27.50% |
| Mar 31, 2025 | 115.76% |
| Dec 31, 2024 | -6,649.88% |
| Sep 30, 2024 | -150.99% |
| Jun 30, 2024 | -74.40% |
| Mar 31, 2024 | 111.57% |
| Dec 31, 2023 | -859.72% |
| Sep 30, 2023 | -195.03% |
| Jun 30, 2023 | -49.78% |
| Mar 31, 2023 | 119.53% |
| Dec 31, 2022 | -33,933,766,908.58% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | -97.61% |
| Mar 31, 2022 | 915,002,195.97% |
| Dec 31, 2021 | 918.16% |
| Sep 30, 2021 | -100.00% |
| Jun 30, 2021 | 97.50% |